Nigeria

Africa

Contents

1. Regulatory Overview
2. Regulatory Pathways
3. Available Drugs

Regulatory Overview

Nigeria is regulated by the NAFDAC (National Agency for Food and Drug Administration and Control). The country has 1 documented regulatory pathway for accessing unapproved or unlicensed medicines, covering named patient programs, compassionate use schemes, and special access arrangements.

Regulatory Authority

NAFDAC (National Agency for Food and Drug Administration and Control)

Regulatory Pathways (1)

NAFDAC Compassionate Use / Expanded Access – Nigeria 30 days

Nigeria NAFDAC compassionate use and expanded access program for unregistered medicines needed by patients with serious or life-threatening diseases.

Application Form: NAFDAC EAP Form

Legal Basis: NAFDAC Act Cap N1 LFN 2004

Eligibility: Serious or life-threatening condition with no locally registered alternative

Reference: NAFDAC Act Cap N1 LFN 2004

Drugs Available (1)

Drug	Access Route	Status	Lead Time
diethylcarbamazine	—	—	—

Nigeria

ISO Code	`NG`
Region	Africa
Regulatory Authority	NAFDAC (National Agency for Food and Drug Administration and Control)
Pathways	1 documented
Drugs Available	1 drug(s)